Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

14,475 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 14,475 results

Early research (Phase 1)Ended earlyNCT03132584
What this trial is testing

Cyclophosphamide and Alemtuzumab In Lymphoma

Who this might be right for
Non Hodgkin LymphomaHigh-grade B-cell LymphomaDiffuse Large B Cell Lymphoma
Dana-Farber Cancer Institute 3
Testing effectiveness (Phase 2)Looking for participantsNCT06414148
What this trial is testing

MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma

Who this might be right for
Relapsed/Refractory Large B-cell Lymphoma
Peter MacCallum Cancer Centre, Australia 40
Early research (Phase 1)Looking for participantsNCT05976555
What this trial is testing

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Who this might be right for
Multiple Myeloma
Medical College of Wisconsin 30
Early research (Phase 1)Study completedNCT01445535
What this trial is testing

Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas

Who this might be right for
T-Cell Peripheral LymphomaGamma Delta Hepatosplenic T-Cell LymphomaSubcutaneous Panniculitis-Like T-Cell Lymphoma+1 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00169208
What this trial is testing

Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Follicular Lymphoma
Lymphoma Study Association 50
Early research (Phase 1)Study completedNCT01065025
What this trial is testing

Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies

Who this might be right for
Advanced and Incurable Solid TumorsMalignant Lymphomas
4SC AG 60
Post-approval studies (Phase 4)Study completedNCT06425276
What this trial is testing

Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation

Who this might be right for
Multiple Myeloma
CASI Pharmaceuticals (China) Co., Ltd. 67
Not applicableUnknownNCT06106776
What this trial is testing

CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

Who this might be right for
Lymphoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 48
Testing effectiveness (Phase 2)WithdrawnNCT03563040
What this trial is testing

Study of Photopheresis in the Treatment of Erythrodermic MF and SS

Who this might be right for
Lymphoma, T-Cell, CutaneousMycosis Fungoides/Sezary Syndrome
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Active Not RecruitingNCT04566887
What this trial is testing

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
University Health Network, Toronto 105
Testing effectiveness (Phase 2)Looking for participantsNCT06712121
What this trial is testing

Venetoclax and Decitabine in R/R T-ALL

Who this might be right for
T Lymphoblastic Leukemia/Lymphoma
Seoul National University Hospital 28
Testing effectiveness (Phase 2)Study completedNCT05338047
What this trial is testing

Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant

Who this might be right for
Myeloma MultipleLymphoma
Hospital Universitario Dr. Jose E. Gonzalez 30
Testing effectiveness (Phase 2)Study completedNCT01261247
What this trial is testing

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+18 more
Mayo Clinic 41
Testing effectiveness (Phase 2)Study completedNCT00217425
What this trial is testing

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 46
Not applicableStudy completedNCT07150468
What this trial is testing

Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

Who this might be right for
Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Lymphoma, Multiple Myeloma
Asan Medical Center 146
Testing effectiveness (Phase 2)Active Not RecruitingNCT04656951
What this trial is testing

Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse

Who this might be right for
Multiple Myeloma
University of Cologne 67
Testing effectiveness (Phase 2)Study completedNCT00891839
What this trial is testing

Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Cephalon 45
Not applicableStudy completedNCT03536975
What this trial is testing

Identify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases and Their Primary Caregivers

Who this might be right for
Cognitive Impairment, MildDementia, Mild
University Hospital, Rouen 48
Not applicableLooking for participantsNCT04957901
What this trial is testing

The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study

Who this might be right for
Lymphoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT00074087
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 49
Next Page